Institute of Diagnostic and Interventional Radiology, Friedrich-Schiller-University Jena, Erlanger Allee 101, D-07740 Jena, Germany.
Eur J Radiol. 2010 Aug;75(2):e18-21. doi: 10.1016/j.ejrad.2009.10.032. Epub 2009 Dec 1.
MR-Mammography (MRM) is regarded as the most sensitive method for detection of breast cancer without a broad consensus on specificity. There is room for improvement of the existing ACR BIRADS lexicon by adding new and specific descriptors. Dilated ducts have been described in association with papillomas. However, the differential diagnostic value of this finding has not been investigated yet.
316 consecutive patients, undergoing histopathologic workup after MR-Mammography were included in this prospective, ethical review board approved study. Two blinded radiologists rated the images in consensus. Ductal obstruction was defined as dilated liquid filled ducts proximal an enhancing lesion. Sensitivity, specificity as well as positive and negative likelihood ratio (LR+, LR-) were calculated.
Dilated ducts were found in 60 cases (19%), 20 of these showed an association with enhancing lesions and were categorized as ductal obstruction (6.3%). Malignancy was found in two cases (one invasive ductal carcinoma and one DCIS) and benign tissue in 18 cases (15 papillomas). The difference of ductal obstruction between these groups was found to be highly significant in two-sided Fisher's exact test (p<0.001). Because of the clear association with benign lesions, benign lesions showing ductal obstruction were characterized as true positive findings. Therefore, following diagnostic parameters were calculated: sensitivity 15.4%, specificity 99.0%, LR+ 15.3, LR- 0.9.
If ductal obstruction is found to be positive, the associated lesion is most likely benign. Therefore, though a rare finding, this descriptor should be taken into account for improved lesion differentiation.
磁共振乳腺成像(MRM)被认为是检测乳腺癌最敏感的方法,但特异性尚无广泛共识。通过添加新的和特定的描述符,可以改进现有的 ACR BIRADS 词汇。扩张的导管与乳头瘤有关。然而,尚未研究这种发现的鉴别诊断价值。
本前瞻性、伦理审查委员会批准的研究纳入了 316 例连续接受 MR 乳腺成像后进行组织病理学检查的患者。两位盲法放射科医生进行了共识评估。导管阻塞定义为增强病变近端扩张的充满液体的导管。计算了敏感性、特异性以及阳性和阴性似然比(LR+、LR-)。
在 60 例(19%)中发现扩张的导管,其中 20 例与增强病变相关,并归类为导管阻塞(6.3%)。发现两例恶性肿瘤(一例浸润性导管癌和一例 DCIS)和 18 例良性组织(15 例乳头瘤)。在双侧 Fisher 精确检验中,导管阻塞在这些组之间的差异具有统计学意义(p<0.001)。由于与良性病变有明确的关联,因此表现为导管阻塞的良性病变被认为是真正的阳性发现。因此,计算了以下诊断参数:敏感性 15.4%,特异性 99.0%,LR+ 15.3,LR- 0.9。
如果发现导管阻塞为阳性,则相关病变很可能为良性。因此,尽管这是一种罕见的发现,但应考虑到这个描述符以提高病变的区分能力。